FMP
Loncar China BioPharma ETF
CHNA
NASDAQ
Inactive Equity
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
13.53 USD
-0.0095 (-0.07021%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
NASDAQ
Description
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
CIK
0001540305
ISIN
US26922A3703
CUSIP
N/A
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Aug 15, 2018
Sector Weightings
We are unable to load the chart at this time.
Country Weightings
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
CHNA Financial Summary
ISIN
US26922A3703
Exchange
NASDAQ
Beta
0.92
Market Cap
0
52-Week
9.76966-22.89
Volume Avg.
534
Price
13.53
Country
US
Management Assets
-
Total Holdings
-
NAV
-
NAV Currency
-
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CHNA News
It looks like there's no news available.
